nach oben

Child's Nervous System

Erschienen in:

09.06.2020 | Original Article

Global trends in the evaluation and management of cerebrospinal fluid shunt infection: a cooperative ISPN survey

verfasst von: Mandana Behbahani, Syed I. Khalid, Sandi K. Lam, Adrian Caceres

Erschienen in: Child's Nervous System | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Ventriculoperitoneal shunts (VPS) is commonly performed by pediatric neurosurgeons and there is no consensus in management of VPS infection as it relates to diagnosis and treatment.

Objective

We utilized an international practitioner-based survey to study the variability in VPS infection diagnostic and therapeutic measures.

Methods

A survey gauging practice patterns of pediatric neurosurgeons regarding VPS and its complication management was distributed. Survey endpoints were analyzed by VPS case volume and pediatric-focused case volume regarding diagnostic measures, use of cerebrospinal fluid (CSF) profile, microbiology, and treatment.

Results

A total of 439 surveys were distributed, with a response rate of 31%. Responders ranged from Americas (44.9%), European (31.4%), Asian (18.6%), African (2.5%), to Australian continents (2.5%). Practitioners were stratified based on number and percentage pediatric VPS performed. Institutions performing highest VPS and percentage pediatric case volumes had lower rate of VPS infection. Shunt tap was the most widely used diagnostic study. Overall CSF profile did not affect decision making towards VPS internalization, except for leukocyte count ≤ 20 × 10⁹/L. Practitioners utilized 3 negative cultures prior to VPS internalization. Discrepancies in surgical management were noted amongst centers with high versus low VPS volume and proportion of pediatric-focused case volume. Practice patterns were not noted to be organism dependent. Antibiotic-impregnated shunts were utilized in the Americas and Europe over other regions but only in one third of all initial VPS or as a preventive strategy after a VPS infection has been resolved respectively.

Discussion

Survey results from 6 continents in VPS management revealed patterns of lower infection in high-volume centers, 3 negative cultures prior to internalization and aggressive surgical VPS infection management in high-volume institutions.

Nur mit Berechtigung zugänglich

Kanik A, Sirin S, Kose E, Eliacik K, Anil M, Helvaci M (2015) Clinical and economic results of ventriculoperitoneal shunt infections in children. Turk Neurosurg 25:58–62. https://doi.org/10.5137/1019-5149.JTN.8540-13.2CrossRefPubMed

Uche EO, Onyia E, Mezue UC, Okorie E, Ozor II, Chikani MC (2013) Determinants and outcomes of ventriculoperitoneal shunt infections in Enugu, Nigeria. Pediatr Neurosurg 49:75–80. https://doi.org/10.1159/000357384CrossRefPubMed

Santos MM, Rubagumya DK, Dominic I, Brighton A, Colombe S, O’Donnell P, Zubkov MR, Härtl R (2017) Infant hydrocephalus in sub-Saharan Africa: the reality on the Tanzanian side of the lake. J Neurosurg Pediatr 20:423–431. https://doi.org/10.3171/2017.5.PEDS1755CrossRefPubMed

Wright Z, Larrew TW, Eskandari R (2016) Pediatric hydrocephalus: current state of diagnosis and treatment. Pediatr Rev 37:478–490. https://doi.org/10.1542/pir.2015-0134CrossRefPubMed

Raffa G, Marseglia L, Gitto E, Germano A (2015) Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants. Childs Nerv Syst 31:1129–1138. https://doi.org/10.1007/s00381-015-2685-7CrossRefPubMed

Kanev PM, Sheehan JM (2003) Reflections on shunt infection. Pediatr Neurosurg 39:285–290. https://doi.org/10.1159/000075255CrossRefPubMed

Vinchon M, Dhellemmes P (2006) Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 22:692–697. https://doi.org/10.1007/s00381-005-0037-8CrossRefPubMed

Reddy GK, Bollam P, Caldito G (2012) Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: long-term single institution experience. World Neurosurg 78:155–163. https://doi.org/10.1016/j.wneu.2011.10.034CrossRefPubMed

Mullan E, Lucas C, Mackie S, Carachi R (2014) Audit of ventriculoperitoneal shunt infections in paediatric patients, 2006-2013. Scott Med J 59:198–203. https://doi.org/10.1177/0036933014548665CrossRefPubMed

10.

Lang J, Amato-Watkins A, Amarasinghe S, Goetz P, Bukhari S, Leach P (2013) One year failure rate for de-novo ventriculo-peritoneal shunts in children from a small volume paediatric neurosurgical unit. Br J Neurosurg 27:503–504. https://doi.org/10.3109/02688697.2012.761674CrossRefPubMed

11.

Okoro BA, Ohaegbulam SC (1995) Experience with ventriculo peritoneal shunts at the University of Nigeria Teaching Hospital, Enugu. East Afr Med J 72:322–324PubMed

12.

Simon TD, Hall M, Riva-Cambrin J et al (2009) Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article. J Neurosurg Pediatr 4:156–165. https://doi.org/10.3171/2009.3.PEDS08215CrossRefPubMedPubMedCentral

13.

Al-Tamimi YZ, Sinha P, Chumas PD et al (2014) Ventriculoperitoneal shunt 30-day failure rate: a retrospective international cohort study. Neurosurgery 74:29–34. https://doi.org/10.1227/NEU.0000000000000196CrossRefPubMed

14.

Paudel P, Bista P, Pahari DP, Sharma GR (2020) Ventriculoperitoneal shunt complication in pediatric hydrocephalus: risk factor analysis from a single institution in Nepal. Asian J Neurosurg 15:83–87. https://doi.org/10.4103/ajns.AJNS_216_19CrossRefPubMedPubMedCentral

15.

Bir SC, Konar S, Maiti TK, Kalakoti P, Bollam P, Nanda A (2016) Outcome of ventriculoperitoneal shunt and predictors of shunt revision in infants with posthemorrhagic hydrocephalus. Childs Nerv Syst 32:1405–1414. https://doi.org/10.1007/s00381-016-3090-6CrossRefPubMed

16.

Schreffler RT, Schreffler AJ, Wittler RR (2002) Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 21:632–636. https://doi.org/10.1097/00006454-200207000-00006CrossRefPubMed

17.

Skar GL, Beaver M, Aldrich A, Lagundzin D, Thapa I, Woods N, Ali H, Snowden J, Kielian T (2019) Identification of potential cerebrospinal fluid biomarkers to discriminate between infection and sterile inflammation in a rat model of Staphylococcus epidermidis catheter infection. Infect Immun 87. https://doi.org/10.1128/IAI.00311-19

18.

Zervos T, Walters BC (2019) Diagnosis of ventricular shunt infection in children: a systematic review. World Neurosurg 129:34–44CrossRefPubMed

19.

Dave P, Venable GT, Jones TL, Khan NR, Albert GW, Chern JJ, Wheelus JL, Governale LS, Huntoon KM, Maher CO, Bruzek AK, Mangano FT, Mehta V, Beaudoin W, Naftel RP, Basem J, Whitney A, Shimony N, Rodriguez LF, Vaughn BN, Klimo P Jr (2019) The preventable shunt revision rate: a multicenter evaluation. Neurosurgery 84:788–798. https://doi.org/10.1093/neuros/nyy263CrossRefPubMed

20.

Omrani O, O’Connor J, Hartley J, James G (2018) Effect of introduction of a standardised peri-operative protocol on CSF shunt infection rate: a single-centre cohort study of 809 procedures. Childs Nerv Syst 34:2407–2414. https://doi.org/10.1007/s00381-018-3953-0CrossRefPubMedPubMedCentral

21.

Lee RP, Venable GT, Vaughn BN, Lillard JC, Oravec CS, Klimo P Jr (2018) The impact of a pediatric shunt surgery checklist on infection rate at a single institution. Neurosurgery 83:508–520. https://doi.org/10.1093/neuros/nyx478CrossRefPubMed

22.

Soleman J, Benvenisti H, Constantini S, Roth J (2017) Conversion of external ventricular drainage to ventriculo-peritoneal shunt: to change or not to change the proximal catheter? Childs Nerv Syst 33:1947–1952. https://doi.org/10.1007/s00381-017-3544-5CrossRefPubMed

23.

Gathura E, Poenaru D, Bransford R, Albright AL (2010) Outcomes of ventriculoperitoneal shunt insertion in sub-Saharan Africa. J Neurosurg Pediatr 6:329–335. https://doi.org/10.3171/2010.7.PEDS09543CrossRefPubMed

24.

Mwachaka PM, Obonyo NG, Mutiso BK, Ranketi S, Mwang’ombe N (2010) Ventriculoperitoneal shunt complications: a three-year retrospective study in a Kenyan national teaching and referral hospital. Pediatr Neurosurg 46:1–5. https://doi.org/10.1159/000314050CrossRefPubMed

25.

Yakut N, Soysal A, Kepenekli Kadayifci E, Dalgic N, Yılmaz Ciftdogan D, Karaaslan A, Akkoc G, Ocal Demir S, Cagan E, Celikboya E, Kanik A, Dagcinar A, Yilmaz A, Ozer F, Camlar M, Turel O, Bakir M (2018) Ventriculoperitoneal shunt infections and re-infections in children: a multicentre retrospective study. Br J Neurosurg 32:196–200. https://doi.org/10.1080/02688697.2018.1467373CrossRefPubMed

26.

Ghritlaharey RK, Budhwani KS, Shrivastava DK, Srivastava J (2012) Ventriculoperitoneal shunt complications needing shunt revision in children: a review of 5 years of experience with 48 revisions. Afr J Paediatr Surg 9:32–39. https://doi.org/10.4103/0189-6725.93300CrossRefPubMed

27.

Lieber BA, Han J, Appelboom G, Taylor BES, Han BJ, Agarwal N, Connolly ES Jr (2016) Association of Steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: a national database analysis. World Neurosurg 89:126–132. https://doi.org/10.1016/j.wneu.2016.01.033CrossRefPubMed

28.

Agarwal N, Shukla RM, Agarwal D et al (2017) pediatric ventriculoperitoneal shunts and their complications: an analysis. J Indian Assoc Pediatr Surg 22:155–157. https://doi.org/10.4103/0971-9261.207624CrossRefPubMedPubMedCentral

29.

Kandasamy J, Dwan K, Hartley JC, Jenkinson MD, Hayhurst C, Gatscher S, Thompson D, Crimmins D, Mallucci C (2011) Antibiotic-impregnated ventriculoperitoneal shunts--a multi-centre British paediatric neurosurgery group (BPNG) study using historical controls. Childs Nerv Syst 27:575–581. https://doi.org/10.1007/s00381-010-1290-zCrossRefPubMed

30.

Sood S, Canady AI, Ham SD (2000) Evaluation of shunt malfunction using shunt site reservoir. Pediatr Neurosurg 32:180–186. https://doi.org/10.1159/000028931CrossRefPubMed

31.

Stamos JK, Kaufman BA, Yogev R (1993) Ventriculoperitoneal shunt infections with gram-negative bacteria. Neurosurgery 33:858–862. https://doi.org/10.1227/00006123-199311000-00011CrossRefPubMed

32.

Turgut M, Alabaz D, Erbey F, Kocabas E, Erman T, Alhan E, Aksaray N (2005) Cerebrospinal fluid shunt infections in children. Pediatr Neurosurg 41:131–136. https://doi.org/10.1159/000085869CrossRefPubMed

33.

Lee JK, Seok JY, Lee JH, Choi EH, Phi JH, Kim SK, Wang KC, Lee HJ (2012) Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years. J Korean Med Sci 27:1563–1568. https://doi.org/10.3346/jkms.2012.27.12.1563CrossRefPubMedPubMedCentral

34.

Habibi Z, Ertiaei A, Nikdad MS, Mirmohseni AS, Afarideh M, Heidari V, Saberi H, Rezaei AS, Nejat F (2016) Predicting ventriculoperitoneal shunt infection in children with hydrocephalus using artificial neural network. Childs Nerv Syst 32:2143–2151. https://doi.org/10.1007/s00381-016-3248-2CrossRefPubMed

35.

Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, van de Beek D, Bleck TP, Garton HJL, Zunt JR (2017) 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated Ventriculitis and meningitis. Clin Infect Dis 64:e34–e65. https://doi.org/10.1093/cid/ciw861CrossRefPubMedPubMedCentral

36.

Kestle JRW, Riva-Cambrin J, Wellons JC et al (2011) A standardized protocol to reduce cerebrospinal fluid shunt infection: the hydrocephalus clinical research network quality improvement initiative. J Neurosurg Pediatr 8:22–29. https://doi.org/10.3171/2011.4.PEDS10551CrossRefPubMedPubMedCentral

37.

Spiegelman L, Asija R, Da Silva SL et al (2014) What is the risk of infecting a cerebrospinal fluid-diverting shunt with percutaneous tapping? J Neurosurg Pediatr 14:336–339. https://doi.org/10.3171/2014.7.PEDS13612CrossRefPubMed

38.

Ozdol C, Gediz T, Basak AT, Basak N, Aghayev K (2019) Shunt tapping versus lumbar puncture for evaluating cerebrospinal fluid infections in a pediatric population. Turk Neurosurg 29:275–278. https://doi.org/10.5137/1019-5149.JTN.24714-18.1CrossRefPubMed

39.

Miller JP, Fulop SC, Dashti SR, Robinson S, Cohen AR (2008) Rethinking the indications for the ventriculoperitoneal shunt tap. J Neurosurg Pediatr 1:435–438. https://doi.org/10.3171/PED/2008/1/6/435CrossRefPubMed

40.

Lenfestey RW, Smith PB, Moody MA, Clark RH, Cotten CM, Seed PC, Benjamin DK Jr (2007) Predictive value of cerebrospinal fluid parameters in neonates with intraventricular drainage devices. J Neurosurg 107:209–212. https://doi.org/10.3171/PED-07/09/209CrossRefPubMed

41.

Lan C-C, Wong T-T, Chen S-J et al (2003) Early diagnosis of ventriculoperitoneal shunt infections and malfunctions in children with hydrocephalus. J Microbiol Immunol Infect 36:47–50PubMed

42.

McClinton D, Carraccio C, Englander R (2001) Predictors of ventriculoperitoneal shunt pathology. Pediatr Infect Dis J 20:593–597. https://doi.org/10.1097/00006454-200106000-00009CrossRefPubMed

43.

Celik U, Celik T, Tolunay O, Donmezer C, Gezercan Y, Mert K, Okten AI (2017) Platelet indices in the diagnosis of ventriculoperitoneal shunt infection in children. Turk Neurosurg 27:590–593. https://doi.org/10.5137/1019-5149.JTN.16659-15.1CrossRefPubMed

44.

Asi-Bautista MC, Heidemann SM, Meert KL, Canady AI, Sarnaik AP (1997) Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 concentrations in cerebrospinal fluid predict ventriculoperitoneal shunt infection. Crit Care Med 25:1713–1716. https://doi.org/10.1097/00003246-199710000-00022CrossRefPubMed

45.

Cotton MF, Hartzenberg B, Donald PR, Burger PJ (1991) Ventriculoperitoneal shunt infections in children. A 6-year study. S Afr Med J 79:139–142PubMed

46.

Hellbusch LC, Penn RG (1989) Cerebrospinal fluid shunt infections by unencapsulated Haemophilus influenzae. Childs Nerv Syst 5:315–317. https://doi.org/10.1007/bf00274521CrossRefPubMed

47.

Shurtleff DB, Loeser JD, Avellino AM, Duguay S, Englund JA, Marcuse EK, Peterson D (2009) Haemophilus influenzae and streptococcus pneumoniae infections in children with cerebrospinal fluid shunts. Pediatr Neurosurg 45:276–280. https://doi.org/10.1159/000228986CrossRefPubMed

48.

Heidari V, Habibi Z, Hojjati Marvasti A, Ebrahim Soltani Z, Naderian N, Tanzifi P, Nejat F (2017) Different behavior and response of staphylococcus epidermidis and streptococcus Pneumoniae to a ventriculoperitoneal shunt: an in vitro study. Pediatr Neurosurg 52:257–260. https://doi.org/10.1159/000477817CrossRefPubMed

49.

Arthur AS, Whitehead WE, Kestle JRW (2002) Duration of antibiotic therapy for the treatment of shunt infection: a surgeon and patient survey. Pediatr Neurosurg 36:256–259. https://doi.org/10.1159/000058429CrossRefPubMed

50.

Gutierrez-Murgas Y, Snowden JN (2014) Ventricular shunt infections: immunopathogenesis and clinical management. J Neuroimmunol 276:1–8. https://doi.org/10.1016/j.jneuroim.2014.08.006CrossRefPubMedPubMedCentral

51.

Sorar M, Er U, Ozisik P et al (2014) The impact of antibiotic-impregnated catheters on ventriculoperitoneal shunt infection. Turkish J Med Sci 44:393–396. https://doi.org/10.3906/sag-1306-15CrossRef

52.

Mallucci CL, Jenkinson MD, Conroy EJ et al (2019) Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation. Lancet 394:1530–1539. https://doi.org/10.1016/S0140-6736(19)31603-4CrossRefPubMedPubMedCentral

53.

Attenello FJ, Garces-Ambrossi GL, Zaidi HA, Sciubba DM, Jallo GI (2010) Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 66:284–289. https://doi.org/10.1227/01.NEU.0000363405.12584.4DCrossRefPubMed

Titel: Global trends in the evaluation and management of cerebrospinal fluid shunt infection: a cooperative ISPN survey
verfasst von: Mandana Behbahani
Syed I. Khalid
Sandi K. Lam
Adrian Caceres
Publikationsdatum: 09.06.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Child's Nervous System / Ausgabe 12/2020
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI: https://doi.org/10.1007/s00381-020-04699-z

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Introduction

Objective

Methods

Results

Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure

Giant nasofrontal meningioma: endoscopic and transcranial approach followed by microvascularized vastus laterallis flap reconstruction

Predicting postoperative tracheostomy requirement in children undergoing surgery for posterior fossa tumors

Role of routine post-operative CT brain following evacuation of extradural haematoma in children: a single-centre experience

Validation of a semiautomated volumetric approach for fetal neurosonography using 5DCNS+ in clinical data from > 1100 consecutive pregnancies

Miller Fisher syndrome following meningococcal meningitis

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“